| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Search the digital library catalog Help

Query: search in
search in
search in
search in
* old and bologna study programme

Options:
  Reset


1 - 3 / 3
First pagePrevious page1Next pageLast page
1.
Challenges posed by novel vaccines in a hyperlinked society both to doctors and the health of their patients
Alojz Ihan, 2018, review article

Abstract: Medicine in the developed world is becoming progressively more commercialized since patients (or, more accurately, medical consumers) are increasingly becoming the driving force of what we call medical progress. The doctors are primarily obliged to treat and help patients, but will always have also (commercial) temptation before him: to facilitate the consumer's desires and, with a warm heart, shoot to the far borders of medical knowledge and technology. A good example illustrating dilemma of beneficial vs commercial medicine are ethical challenges of some new vaccines developed recently. Since their earliest introduction in the late 18th century, vaccines have undoubtedly saved the lives of millions, while also fundamentally changing the way modern medicine is practiced. Many diseases that were once widespread are now eradicated, yet vaccine development faces ongoing challenges, including some important ethical considerations. Today there are over 300 vaccines in development and included in clinical trials. Among them, anti-addiction vaccines (Cocaine, Nicotine, Fentanyl, Heroin, Oxycodone) received a burst of media attention, because these vaccines could help people in recovery from addiction; however, many ethical and legal questions may arise before clinical use.
Keywords: conflicts of interest, physicians, commercialization, public health
Published: 09.10.2018; Views: 649; Downloads: 56
.pdf Full text (444,21 KB)
This document has many files! More...

2.
Commercialization methods of a new product/service in ICT industry
Alireza Aslani, Hossein Eftekhari, Mahdi Hamidi, Bahareh Nabavi, 2015, original scientific article

Abstract: Purpose: Commercialization is a step toward new products/services development. Due to high rate of product/service failure in ICT industry, the purpose of this paper is to study and evaluate commercialization methods implemented by companies that operate within ICT industry at the Science and Technology Park of University of Tehran. Design/Methodology/Approach: The methodology of this study is of field research type. After examining commercialization methods presented in the literature and confirming methods found by the discipline elite, structured interviews were conducted addressed managers and experts of ICT companies. Results: Three methods of “joint research contracts”, “exhibitions” and “spin-offs” are among the most common commercialization methods used by companies. Conclusion: Due to uncertainties that exist in ICT industry, companies should consider different strategies in order to develop successful products and services. Finally, specific policies are determined to implement each commercialization method in knowledge-based companies.
Keywords: innovation, commercialization, ICT, science and technology park
Published: 29.11.2017; Views: 414; Downloads: 112
.pdf Full text (374,15 KB)
This document has many files! More...

3.
Challenges in commercializing biomimetic membranes
Mark Edward Perry, Steen Ulrik Madsen, Tine Jørgensen, Sylvia Braekevelt, Karsten Lauritzen, Claus Hélix-Nielsen, 2015, review article

Abstract: The discovery of selective water channel proteins-aquaporins-has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market%in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes.
Keywords: aquaporin membranes, biomimetic, commercialization, early stage technology
Published: 21.06.2017; Views: 633; Downloads: 267
.pdf Full text (239,48 KB)
This document has many files! More...

Search done in 0.09 sec.
Back to top
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica